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We have determined the infusion rates of rocuronium in the
elderly and young adult patients during sevoflurane and nitrous
oxide anesthesia. The correlation of some anthropometric pre-
dictors with infusion rate of rocuronium was also investigated
for both elderly and young adult. Participating patients were
assigned to one of two groups: 1) young adult patients aged
20 to 50 years (n = 30); 2) elderly patients aged over 65 years
(n = 30). The anthropometric variables such as height, weight,
ratio of weight to body surface area, subscapularis and
suprailiac skin folds, body surface area, body mass index and
% ideal body weight were evaluated as predictors for infusion
rate. The infusion rate in elderly patients was significantly less
compared with that in young adult patients (p < 0.05). In
elderly patients, no anthropometric predictor was related to the
infusion rate of rocuronium. This suggests that the infusion
rate of rocuronium for an elderly patient needs to be
individualized by monitoring neuromuscular transmission to
avoid excessive dose.
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INTRODUCTION
The infusion rate of a drug is based frequently
on body weight. There is a progressive decline in
lean body mass and, particularly, in muscle with
aging, and blood volume and extracellular fluid
also diminish with age. Hence, the central volume
of distribution for highly polar compounds should
be smaller, and the dosage based on body weight
will result in a higher initial plasma concentra-
tions than for the young adult.
1 The decreased
total body water and liver mass, which normally
accompany aging, are likely explanations for the
prolonged duration of action for the neuromu-
scular blockade compounds in the elderly.
2,3
Various pharmacokinetic factors may also be in-
volved in the delivery of a drug.
Rocuronium bromide is structural analogue
(2-morpholino, 3-hydroxy, 16N-allylpyrrolidino
derivative) of vecuronium with a neuromuscular
blocking potency 6-7 times less that of vecuro-
nium. This lack of potency is thought to be an
important factor in determining the rapid onset of
neuromuscular block.
4,5 Rocuronium is a non-
depolarizing muscle relaxant with an intermediate
duration of action and insignificant accumulation,
and it is well suited for continuous infusion.
6-8
Rocuronium is eliminated primarily by the liver
and to a slight degree by the kidneys. Because
rocuronium does not have active metabolites,
9 it
may be a better choice than vecuronium for
prolonged infusion.
The infusion rate of rocuronium for an adequate
surgical operation was suggested to be 6.1 ± 2.0 μ
g/kg/min
10 and 8.4 ± 1.6 g/kg/min μ
8 for adult
and pediatric patients, respectively, during sevo-
flurane anesthesia, while there has been no report
yet on the optional dosage for elderly patients.
The aim of this study was to determine the in-
fusion rate of rocuronium necessary to maintain
a stable and suitable level of neuromuscular
blockade for surgery in young adults and the
elderly patients. We also evaluated different an-
thropometric variables such as body weight, ratio
of weight to body surface area (BSA), sum of
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subscapularis and suprailiac skin folds, body mass
index (BMI) and percentage of ideal body weight
(%IBW) as indices for the optimization of rocuro-
nium administration to each individual patient.
MATERIALS AND METHODS
After obtaining approval from the Local Ethics
Committee and written informed consent, 60
patients (ASA physical status I or II) who were
scheduled for elective orthopedic surgery under
general anesthesia were assigned into two groups:
1) young adult patients aged 20 to 50 years (con-
trol group, n = 30); 2) elderly patients aged over
65 years (elderly group, n = 30). Exclusion criteria
were body weight more or less than 20% of the
ideal body weight, expected difficult intubation,
pre-existing hepatic, renal and neuromuscular
disease, allergic diathesis, pregnancy or breast-
feeding and preoperative medication known to
interact with non-depolarizing neuromuscular
blocking agents.
Anthropometric variables such as height, weight,
and subscapularis and suprailiac skin folds were
measured before the induction of anesthesia. BSA
was estimated using the formula of Du Bois and
Du Bois
11 (0.007184×height [cm]
0.725×weight [kg]
0.425) and BMI calculated as total body weight
divided by the squared height.
12 Calculation of the
ideal body weight (IBW) was based on the for-
mula of Devine
13,14 {50 kg + 2.3×(height [inch]-60)
for man and 45.5 kg + 2.3×(height [inch]-60) for
woman}.
Patients were premedicated with glycopyrrolate
0.2 mg and midazolam 2.0 mg that was given in-
tramuscularly 30 min before surgery. Each patient
was given a standard general anesthetic consisting
of fentanyl, thiopental sodium, 50% nitrous oxide
and 3% sevoflurane in oxygen. The neuromus-
cular blockade was monitored using an accelero-
graph TOF-Watch (Organon, Teknica B.V., Boxtel,
the Netherlands). The patient's arm used for
neuromuscular monitoring was fixed to an arm
board. The ulnar nerve was stimulated transcu-
taneously at the wrist via reference electrodes.
After calibration, supramaximal stimuli of 0.2 ms
duration in a single twitch mode at 1 Hz were
used until the end of the study. The software that
the computer used to record the responses was
TOF-Watch . Another anesthesiologist behind a
screen, who positively could not see the patient,
observed only the TOF-Watch and then he or she
adjusted the infusion rate of rocuronium. Non-
invasive blood pressure was measured on an arm,
and the arm was not used for the evaluation of
neuromuscular transmission. Fluids were given
via an intravenous cannula inserted proximal to
the area of nerve stimulation.
An ED95 dosage (0.3 mg/kg) of rocuronium
was administered via a forearm vein and then
tracheal intubation was performed when the
maximal depression of the twitch response was
reached. When the height of the single twitch
recovered up to 15% of the control twitch re-
corded before induction of the neuromuscular
block, the continuous infusion of rocuronium was
initiated. The continuous infusion rate was
determined when the single twitch response was
maintained at 10 ± 5% for more than 10 minutes
and forty minutes after 1.5-2.0% sevoflurane was
reached.
10 Mechanical ventilation was adjusted to
maintain the end-tidal carbon dioxide partial pres-
sure between 30 and 35 mmHg. Body temperature
was monitored continuously in the upper esoph-
agus and at the thenar eminence of the same arm
used for neuromuscular monitoring. Core tem-
perature and skin temperature were maintained at
greater than 36.0 and 32.0 , respectively.
Data were expressed as means ± standard de-
viation. The anthropometric variables and infu-
sion rates of the two groups were compared by
t-test and a p-value < 0.05 was considered statisti-
cally significant. The linear regression analysis
was used to test the relations between the anthro-
pometric variables and the infusion rate. To
determine the correlation, individual values of
each anthropometric parameter were also plotted
against the infusion rate provided. Data were
analyzed using SPSS for Windows software (SPSS
11.0, Chicago, IL, USA).
RESULTS
There were no significant differences between
the young adult and the elderly patients for the
anthropometric variables like height, weight, BSA,Predictors for Infusion Rate of Rocuronium in the Elderly
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BMI, %IBW, ratio of body weight to BSA and the
sum of subscapularis and suprailiac skin folds.
The infusion rate of rocuronium (2.9 ± 1.0 g/kg/ μ
min) in elderly patients was significantly less than
that of young adults (4.2 ± 1.6 g/kg/min) ( μ p <
0.05, Table 1).
The infusion rate of rocuronium in young
adults correlated with the sum of subscapularis
and suprailiac skin folds (r
2 = 0.23, p = 0.007, Fig.
1). However, the elderly did not show any correla-
tion with the anthropometric variables.
DISCUSSION
The present study demonstrated that the infu-
sion rate of rocuronium in the elderly under sevo-
flurane anesthesia was about 69% less compared
to that in the young adults.
This is consistent with earlier findings for vecu-
ronium in other study. The vecuronium infusion
rate was 70% less in the elderly than that in the
young adults.
15 The most reasonable explanation
for the decrease of the infusion rate in the elderly
would be a decrease in drug elimination capacity
noted with aging. In addition, pharmacokinetic
changes in the elderly such as reduction in the
total body water and liver mass may result in a
prolonged effect of rocuronium.
3,16
The continuous infusion of a neuromuscular
blocking agent stabilizes the blood concentration
of the drug maintains the degree of neuromu-
scular relaxation constant.
17 When the infusion
dosage is adjusted to the appropriate indivi-
dualized demand for each patient, it is possible to
avoid excessive neuromuscular relaxation by re-
ducing the total drug requirement. A more rapid
recovery from the neuromuscular relaxation by
Table 1. Characteristics of Patients, Anthropometric Variables and Infusion Rate
Parameters Young Elderly
Number of patients
Male/Female
Age (years)
Body weight (kg)
Height (cm)
BSA (m
2)
BMI (kg/cm
2)
IBW %
Body weight/BSA (kg/m
2)
Sub SF + Si SF (mm)
Infusion rate ( g/kg/min) μ
30
14/16
35.0 ± 12.2
61.2 ± 12.8
164.6 ± 8.7
1.66 ± 0.20
22.5 ± 3.3
95.8 ± 13.2
36.4 ± 3.5
27.6 ± 14.1
4.2 ± 1.6
30
19/11
71.3 ± 5.8*
58.5 ± 9.5
161.8 ± 8.4
1.61 ± 0.16
22.3 ± 2.4
94.6 ± 11.0
36.0 ± 2.5
25.8 ± 12.6
2.9 ± 1.0*
Note, Values are as means ± SD or number.
*p < 0.05 when compared with young patients
Young, > 20 year-old and < 50 year-old patients; Elderly, > 65 year-old patients.
BSA, body surface area; BMI, body mass index; %IBW, body weight in percent of ideal body weight; Sub SF, subscapularis
skin fold; Si SF, suprailiac skin fold.
Fig. 1. Sum of subscapular skin folds and suprailiac skin
folds plotted against the infusion rate of rocuronium for
the young patients group. The infusion rate of rocuro-
nium for young adults correlated with the sum of sub-
scapularis and suprailiac skin folds (linear regression: SF=
44.64 + [- 0.47] (rate, r
2 = 0.23, p = 0.007). SF, sum of sub-
scapular skin folds and suprailiac skin folds.Bon Nyeo Koo, et al.
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using a proper antagonist within a short time after
the infusion termination is a decided advantage.
18
However, neuromuscular monitoring is a neces-
sity because interindividual differences do exist.
19
Infusion rates based on weight may provide a
relatively excessive dosage to the elderly because
of their pharmacokinetic differences. If other
anthropometric besides body weight can predict
infusion rate, they can be clinically useful indices.
As for the initial infusion rate, the infusion rate
of rocuronium in elderly patients should be
reduced since the infusion rate needed to produce
adequate surgical relaxation in the elderly was
significantly less than that used in the young
adult. The infusion rate in the elderly must be
individualized for the special requirement of each
patient, and this means starting at a lower infu-
sion rate for the elderly.
It has been suggested in several studies that
the volatile anesthetics elicit strengthening of the
neuromuscular relaxation.
8,10,17,20-22 In particular,
when compared with the intravenous anesthetic,
propofol, the use of a volatile anesthetic de-
creases the infusion rate of rocuronium by 40%.
10
The infusion rate of rocuronium in this study
was lower than those reported in the previous
studies
4,7,8,17,21,22 presumably due to the neuro-
muscular blocking effect of sevoflurane. Al-
though the exact mechanism of neuromuscular
relaxation by a volatile anesthetic has not been
elucidated, an interaction between a volatile
anesthetic and a neuromuscular blocking agent is
known to enhance the inhibition of the muscular
contraction and to move a neuromuscular
blocking agent dosage-response curve to the left
(the decrease of ED50, ED95).
17
In young adults, the sum of subscapularis and
suprailiac skin folds is the best predictor for the
infusion rate of rocuronium. Therefore, the infu-
sion rate of rocuronium should logically be based
on the sum of subscapularis and suprailiac skin
folds. Using the sum of subscapularis and sup-
railiac skin folds to determine the infusion rate is
a safe method even in the obese patients because
the prolongation of the muscle relaxant effect is
avoided since an overdose is prevented.
23 The
elderly did not show any correlation with stan-
dard anthropometric variables.
The skin fold measurement predicts the body
density and is used to calculate the body mass
percentage. The skin folds can be measured at
several regions such as thigh, abdomen, triceps,
biceps, chest, subscapularis and suprailiac regions.
Among these, only the subscapularis and sup-
railiac skin folds were measured in our study
because it was not necessary to measure the skin
folds on several regions, since a significant result
was obtained from previous studies for vecuro-
nium by applying the sum of subscapularis and
suprailiac skin folds.
24
The continuous infusion rate of rocuronium
based on the 10% twitch height with accelero-
graphy under sevoflurane anesthesia for the
elderly over 65 years old was 2.9 ± 1.0 g/kg/ μ
min. Unlike young adults, there were no signifi-
cant anthropometric predictors to determine the
infusion rate of rocuronium in the elderly. From
these results it was concluded that the infusion
rate of rocuronium in the elderly should be
reduced and an adequate infusion rate has to be
individualized by the use of a neuromuscular
monitor.
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